Ultimately, it is hoped that such inhibitory effects on coronaviral attachment can be translated into antiviral activity against the COVID-19-causing SARS-CoV-2 and maybe even other CoVs that bind to ACE2 such as SARS-CoV and the α-coronavirus HCoV-NL63. Here, ACE2 is linked to COVID-19.